The r18 polyarginine peptide is more effective than the tat-nr2b9c (na-1) peptide when administered 60 minutes after permanent middle cerebral artery occlusion in the rat

HIGHLIGHTS

• who: TAT-NR et al. from the School of Health Sciences, The University of Notre Dame Australia, Fremantle, WA, Australia have published the article: The R18 Polyarginine Peptide Is More Effective Than the TAT-NR2B9c (NA-1) Peptide When Administered 60 Minutes after Permanent Middle Cerebral Artery Occlusion in the Rat, in the Journal: (JOURNAL) of 24/02/2016
• what: The results of this study add to the previous findings, which showed that 1000 nmol/kg R18 when administered 30 minutes after permanent MCAO significantly reduces infarct volume in the rat .
• how: The . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.